The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

TAS-102 vs placebo (PBO) in patients (pts) ≥65 years (y) with metastatic colorectal cancer (mCRC): An age-based analysis of the RECOURSE trial.

Eric  Van Cutsem

Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Merck Serono (Inst); Novartis (Inst); Roche (Inst); Sanofi (Inst)

Fabio M.  Benedetti

Employment - Taiho Pharmaceutical

Leadership - Taiho Pharmaceutical

Hirokazu  Mizuguchi

Employment - Taiho Pharmaceutical

Stock and Other Ownership Interests  - Taiho Pharmaceutical

Robert J.  Mayer

Honoraria - Amgen; AstraZeneca

Atsushi  Ohtsu

Employment - Celgene (I)

Honoraria - Chugai Pharma; Daiichi Sankyo; Eisai; Merck Serono; Taiho Pharmaceutical